These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1765 related articles for article (PubMed ID: 28642843)

  • 21. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.
    Liu J; Tran V; Leung AS; Alexander DC; Zhu B
    Hum Vaccin; 2009 Feb; 5(2):70-8. PubMed ID: 19164935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system.
    Bottai D; Frigui W; Clark S; Rayner E; Zelmer A; Andreu N; de Jonge MI; Bancroft GJ; Williams A; Brodin P; Brosch R
    Vaccine; 2015 May; 33(23):2710-8. PubMed ID: 25869896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex.
    Collins DM
    Immunol Cell Biol; 2000 Aug; 78(4):342-8. PubMed ID: 10947858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays.
    Gordon SV; Brosch R; Billault A; Garnier T; Eiglmeier K; Cole ST
    Mol Microbiol; 1999 May; 32(3):643-55. PubMed ID: 10320585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.
    Jackson M; Phalen SW; Lagranderie M; Ensergueix D; Chavarot P; Marchal G; McMurray DN; Gicquel B; Guilhot C
    Infect Immun; 1999 Jun; 67(6):2867-73. PubMed ID: 10338493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.
    Sali M; Di Sante G; Cascioferro A; Zumbo A; Nicolò C; Donà V; Rocca S; Procoli A; Morandi M; Ria F; Palù G; Fadda G; Manganelli R; Delogu G
    Infect Immun; 2010 Dec; 78(12):5202-13. PubMed ID: 20921146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis.
    Bao L; Chen W; Zhang H; Wang X
    Infect Immun; 2003 Apr; 71(4):1656-61. PubMed ID: 12654778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen.
    Spratt JM; Britton WJ; Triccas JA
    Bioeng Bugs; 2010; 1(1):61-5. PubMed ID: 21327127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains.
    Mattow J; Jungblut PR; Schaible UE; Mollenkopf HJ; Lamer S; Zimny-Arndt U; Hagens K; Müller EC; Kaufmann SH
    Electrophoresis; 2001 Aug; 22(14):2936-46. PubMed ID: 11565788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary-phase cultures.
    Collins DM; Wilson T; Campbell S; Buddle BM; Wards BJ; Hotter G; de Lisle GW
    Microbiology (Reading); 2002 Oct; 148(Pt 10):3019-3027. PubMed ID: 12368435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen.
    Chiwala G; Liu Z; Mugweru JN; Wang B; Khan SA; Bate PNN; Yusuf B; Hameed HMA; Fang C; Tan Y; Guan P; Hu J; Tan S; Liu J; Zhong N; Zhang T
    Biomed Pharmacother; 2021 Oct; 142():112047. PubMed ID: 34426260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microevolution of BCG substrains.
    Krysztopa-Grzybowska K; Lutyńska A
    Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1259-1266. PubMed ID: 28026828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPE37 Is Essential for
    Tullius MV; Nava S; Horwitz MA
    Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30455201
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
    Majlessi L; Brodin P; Brosch R; Rojas MJ; Khun H; Huerre M; Cole ST; Leclerc C
    J Immunol; 2005 Mar; 174(6):3570-9. PubMed ID: 15749894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.